Document Detail


Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.
MedLine Citation:
PMID:  14530778     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The liver is a common site of amyloid deposition in primary systemic amyloidosis. We reviewed the clinical features and natural history of patients with primary systemic amyloidosis and biopsy-proven hepatic involvement who were evaluated at Mayo Clinic from January 1, 1975, to December 31, 1997. The median age of the study group (68 men; 30 women) was 58.5 years. Seventy-one patients (72%) had involuntary weight loss. Hepatomegaly was found in 79 patients (81%). Eighty-two patients (89%) had proteinuria, and 81 patients (86%) had elevated serum alkaline phosphatase levels. Seventy-six patients (83%) had either a serum or urine monoclonal protein. Before liver biopsy, clinicians considered amyloidosis in the differential diagnosis for only 14 patients (26%). None of our patients experienced hepatic rupture or death due to liver biopsy, and only 4 (4%) bled after liver biopsy. The median survival of the 98 patients was 8.5 months. Predictors of a poor prognosis were congestive heart failure, elevated concentrations of bilirubin, and a platelet count greater than 500 x 109/L. In conclusion, clinicians should consider the diagnosis of primary hepatic amyloidosis in patients who present with involuntary weight loss or hepatomegaly. Other clues to the diagnosis include an unexplained elevated serum alkaline phosphatase level, proteinuria, and evidence for hyposplenism (for example, Howell-Jolly bodies on peripheral blood smear). Liver biopsy was safe. Some patients benefit from systemic chemotherapy.
Authors:
Miguel A Park; Paul S Mueller; Robert A Kyle; Dirk R Larson; Matthew F Plevak; Morie A Gertz
Related Documents :
17968998 - Partial splenectomy for portal hypertension in cystic fibrosis related liver disease.
18332928 - Telomerase activity, p53 mutation and ki-ras codon 12 point mutation of the peripheral ...
6972178 - Prognostic factors in histiocytosis x.
15922888 - Doppler perfusion index fails to predict the presence of occult hepatic colorectal meta...
3827678 - Influence of dietary protein on motor fluctuations in parkinson's disease.
7595878 - Globus pharyngis: development of a symptom assessment scale.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Medicine     Volume:  82     ISSN:  0025-7974     ISO Abbreviation:  Medicine (Baltimore)     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-10-07     Completed Date:  2003-11-06     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  2985248R     Medline TA:  Medicine (Baltimore)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  291-8     Citation Subset:  AIM; IM    
Affiliation:
Division of General Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amyloidosis / pathology*
Female
Follow-Up Studies
Humans
Liver Diseases / pathology*
Liver Function Tests
Male
Middle Aged
Multivariate Analysis
Prognosis
Proportional Hazards Models
Survival Analysis
Grant Support
ID/Acronym/Agency:
CA 62242/CA/NCI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pneumonia in the intensive care unit.
Next Document:  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of ear...